Impedimetric detection of mutant p53 biomarker-driven metastatic breast cancers under hyposmotic pressure.
In cancer cells, the oncogenic mutant p53 (mtp53) protein is present at high levels and gain-of-function (GOF) activities with more expression of mtp53 proteins contribute to tumor growth and metastasis. Robust analytical approaches that probe the degree of metastasis of cancer cells in connection w...
Main Authors: | Menglu Shi, Nataly Shtraizent, Alla Polotskaia, Jill Bargonetti, Hiroshi Matsui |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4060997?pdf=render |
Similar Items
-
Identification, validation, and targeting of the mutant p53-PARP-MCM chromatin axis in triple negative breast cancer
by: Wei-Gang Qiu, et al.
Published: (2017-01-01) -
Endogenous human MDM2-C is highly expressed in human cancers and functions as a p53-independent growth activator.
by: Danielle R Okoro, et al.
Published: (2013-01-01) -
Oligomerization of Mutant p53 R273H is not Required for Gain-of-Function Chromatin Associated Activities
by: George K. Annor, et al.
Published: (2021-11-01) -
Mutant <i>C. elegans</i> p53 Together with Gain-of-Function GLP-1/Notch Decreases UVC-Damage-Induced Germline Cell Death but Increases PARP Inhibitor-Induced Germline Cell Death
by: Jorge Canar, et al.
Published: (2022-10-01) -
Evidence of Coordinated and Adjustable Osmolytes Movements Following Hyposmotic Swelling in Rainbow Trout Red Blood Cells
by: Valérie Maxime
Published: (2021-10-01)